Urgent strategies needed to fight artemisinin resistance in East Africa

FHS
July 19, 2024
5:01 am

Artemisinin-based combination therapies (ACTs) have become the cornerstone of malaria treatment and control.

STAT readers on burnt-out infectious disease doctors, 12-month prescriptions, and counting disabled Americans

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a

December 2, 2023

Psychostimulant No Help in Relieving Cancer-Related Fatigue

Six weeks of treatment with methylphenidate did no better than placebo for improving cancer-related fatigue (CRF). The results continued a pattern of inconsistency in outcomes

May 23, 2024

After CRISPR baby scandal shut down work for years, China gene editing companies are restarting clinical trials

A half-decade after a scientist’s reckless experiment with human embryos put a stop to much of China’s clinical work on CRISPR gene editing, local researchers

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.